Source link : https://www.newshealth.biz/health-news/amgens-obesity-drug-cuts-weight-by-up-to-20-trial-data-drags-down-shares/
(Reuters) -Amgen’s experimental drug MariTide helped overweight or obese patients lose up to 20% weight on average in a year-long mid-stage trial, data that missed lofty investor expectations and sent the shares down 8% before the bell on Tuesday. Ahead of the results, some analysts had said 20% weight loss was the minimum bar and […]
Author : News Health
Publish date : 2024-11-26 12:09:56
Copyright for syndicated content belongs to the linked Source.
Categories